Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 125,676 | 1,195 | 1,648 | 641 | 0 |
| Gross Profit | 125,676 | 1,195 | 1,648 | 641 | 0 |
| Operating Expenses | 50,954 | 39,159 | 59,030 | 26,389 | 23,560 |
| Operating Income | 74,722 | -37,964 | -57,382 | -25,748 | -23,560 |
| Other Income | 2,811 | 2,593 | 2,658 | 2,070 | 665 |
| Pre-tax Income | 77,533 | -35,371 | -54,724 | -23,678 | -22,895 |
| Net Income Continuous | 77,533 | -35,371 | -54,724 | -23,678 | -22,887 |
| Net Income | $77,533 | $-35,371 | $-54,724 | $-23,678 | $-22,887 |
| EPS Basic Total Ops | 0.84 | -0.38 | -0.59 | -0.26 | -0.74 |
| EPS Basic Continuous Ops | 0.84 | -0.38 | -0.59 | -0.26 | -0.74 |
| EPS Diluted Total Ops | 0.84 | -0.38 | -0.59 | -0.26 | -0.74 |
| EPS Diluted Continuous Ops | 0.84 | -0.38 | -0.59 | -0.26 | -0.74 |
| EBITDA(a) | $76,260 | $-36,409 | $-56,232 | $-25,281 | $-22,904 |